UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); CANA Standout at ADA
Tweet Send to a Friend
UBS maintains a 'Buy' on Johnson & Johnson (NYSE: JNJ) price target of $70.00.
Analyst, Rajeec Jashnani, commented on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Rajeec Jashnani, commented on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


